A Challenging Case of Carcinoid Crisis in a Patient With Neuroendocrine Tumor

被引:1
作者
Mahdi, Mohammed [1 ]
Ozer, Muhammet [1 ]
Tahseen, Muhammad [2 ]
机构
[1] Capital Hlth Syst, Internal Med, Trenton, NJ 08638 USA
[2] Capital Hlth Syst, Crit Care Med, Trenton, NJ USA
关键词
carcinoid crisis; neuroendocrine tumor; octreotide; hypotension; shock; COMPLICATIONS; OCTREOTIDE; BOLUS;
D O I
10.7759/cureus.15626
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The critical state of circulatory collapse and hypoperfusion that results in end-organ damage has been called shock. Carcinoid crisis is a rare cause of shock, which is difficult to identify in the presence of infection. It occurs due to the release of vasoactive amines into the systemic circulation following an inciting event. In the presence of a neuroendocrine tumor, carcinoid crisis should be suspected in case of resistant shock. Herein, we report a rare case of carcinoid crisis, in which a quick response to the somatostatin analog therapy, octreotide, was helpful to confirm the diagnosis.
引用
收藏
页数:5
相关论文
共 13 条
  • [1] Carcinoid tumour
    Caplin, ME
    Buscombe, JR
    Hilson, AJ
    Jones, AL
    Watkinson, AF
    Burroughs, AK
    [J]. LANCET, 1998, 352 (9130) : 799 - 805
  • [2] Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis
    Condron, Mary E.
    Pommier, SuEllen J.
    Pommier, Rodney F.
    [J]. SURGERY, 2016, 159 (01) : 358 - 365
  • [3] Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
    Dasari, Arvind
    Shen, Chan
    Halperin, Daniel
    Zhao, Bo
    Zhou, Shouhao
    Xu, Ying
    Shih, Tina
    Yao, James C.
    [J]. JAMA ONCOLOGY, 2017, 3 (10) : 1335 - 1342
  • [4] B-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor
    Limbach, Kristen E.
    Condron, Mary E.
    Bingham, Ann E.
    Pommier, SuEllen J.
    Pommier, Rodney F.
    [J]. AMERICAN JOURNAL OF SURGERY, 2019, 217 (05) : 932 - 936
  • [5] The spectrum of carcinoid tumours and carcinoid syndromes
    Lips, CJM
    Lentjes, EGWM
    Höppener, JWM
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2003, 40 : 612 - 627
  • [6] Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients
    Massimino, Kristen
    Harrskog, Ola
    Pommier, Suellen
    Pommier, Rodney
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (08) : 842 - 846
  • [7] Current status of gastrointestinal carcinoids
    Modlin, IM
    Kidd, M
    Latich, I
    Zikusoka, MN
    Shapiro, MD
    [J]. GASTROENTEROLOGY, 2005, 128 (06) : 1717 - 1751
  • [8] Complications from carcinoid syndrome: review of the current evidence
    Mota, Jose Mauricio
    Sousa, Luana Guimaraes
    Riechelmann, Rachel P.
    [J]. ECANCERMEDICALSCIENCE, 2016, 10
  • [9] Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
    Sansone, Andrea
    Lauretta, Rosa
    Vottari, Sebastiano
    Ari, Alfonsina Chief
    Barnabei, Agnese
    Romanelli, Francesco
    Appetecchia, Marialuisa
    [J]. CANCERS, 2019, 11 (08)
  • [10] Seymour N, 2013, CAN J ANESTH, V60, P492, DOI 10.1007/s12630-012-9879-1